ADD ANI AS A TRUSTED SOURCE
googleads
Menu
General News

Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials

New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.

ANI Jan 28, 2022 15:06 IST googleads

Representative Image

New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) had also recommended the internasal vaccine clinical trials during the last meeting.
The NOC letter issued by the DCGI read, "Central Licensing Authority hereby permits Bharat Biotech International limited to conduct clinical trials of the new drug or investigational new drug."
The dosage form of the vaccine is liquid for the intranasal route of administration and every single dose contains 0.5ml.
The trials of the Intranasal vaccine will take place at nine different sites of the country.
The trials will be conducted at Atman Hospital, Ahmedabad, Gujarat; AIIMS, Delhi and Patna; Oyster and Pearls Hospitals, Pune; Pt.BD Sharma Postgraduate Institute of Medical Sciences at Rohtak, Haryana; Acharya Vinobha Bhave Rural Hospital, Wardha; Jeevan Rekha Hospital, Belagavi; Rana hospital, Gorakhpur; and Prakhar Hospital, Uttar Pradesh.
"The Phase -3 clinical trial should be conducted as per protocol multi-center study to compare immunogenicity and safety of BBV154 with COVAXIN." read the letter. (ANI)

Get the App

What to Read Next

Politics

Giriraj Singh slams Rahul Gandhi over conduct in Parliament

Giriraj Singh slams Rahul Gandhi over conduct in Parliament

Speaking to reporters here on Thursday, Singh said the opposition had sought permission to speak on the issue of LPG, but did not adhere to the subject.

Read More
General News

TMC's jibe at Centre amid LPG crisis due to West Asia conflict

TMC's jibe at Centre amid LPG crisis due to West Asia conflict

In an 'X' post, TMC said the government has "ek hi naara, line mein rahe desh bechara," pointing to past governmental measures including demonetisation, the COVID-19 vaccine rollout, the Special Identification Registration (SIR), and now the LPG shortage. The party described demonetisation as a "Tughlaqi farman" that forced ordinary citizens to wait in serpentine queues outside banks and ATMs for days to access their own money. The post also highlighted the 2020 COVID-19 oxygen crisis, when families stood in long lines outside hospitals and suppliers as the public health system collapsed.

Read More
General News

Delimitation schedule released for 3 urban bodies in Himachal

Delimitation schedule released for 3 urban bodies in Himachal

As per the schedule, the draft proposal for the delimitation of wards will be published on March 12. Residents of the concerned municipal areas can submit objections or suggestions till March 19.

Read More
General News

AI Summit protest case: Patiala House Court to hear

AI Summit protest case: Patiala House Court to hear

Delhi police have alleged that Manish Sharma was the key conspirator behind the planning of the 'shirtless' protest at the AI Impact Summit at Bharat Mandapam on February 20. A Non-Bailable Warrant has also been issued against him.

Read More
General News

Kiren Rijiju criticises Rahul Gandhi for ignoring dicussion on LP

Kiren Rijiju criticises Rahul Gandhi for ignoring dicussion on LP

Union Parliamentary Affairs Minister Kiren Rijiju on Thursday criticised Leader of Opposition in Lok Sabha, Rahul Gandhi, saying he ignored special permission to speak on the LPG shortage and instead raised another issue.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.